Cite
Synthetic Polypeptide Derived from Viral Macrophage Inflammatory Protein II Inhibit VEGF Production of Human Glioma U87 Cells through SDF-1a/CXCR4-Mediated AKT Signaling Pathway.
MLA
Bo Xu, et al. “Synthetic Polypeptide Derived from Viral Macrophage Inflammatory Protein II Inhibit VEGF Production of Human Glioma U87 Cells through SDF-1a/CXCR4-Mediated AKT Signaling Pathway.” Tropical Journal of Pharmaceutical Research, vol. 13, no. 8, Aug. 2014, pp. 1327–32. EBSCOhost, https://doi.org/10.4314/tjpr.v13i8.18.
APA
Bo Xu, Peng Tian, Gui-Jie An, Sha Liu, Xiu-Ying Li, Han-Xiao Sun, Jing-Gung Zhou, Qing Ding, & Pi-Jin Wei. (2014). Synthetic Polypeptide Derived from Viral Macrophage Inflammatory Protein II Inhibit VEGF Production of Human Glioma U87 Cells through SDF-1a/CXCR4-Mediated AKT Signaling Pathway. Tropical Journal of Pharmaceutical Research, 13(8), 1327–1332. https://doi.org/10.4314/tjpr.v13i8.18
Chicago
Bo Xu, Peng Tian, Gui-Jie An, Sha Liu, Xiu-Ying Li, Han-Xiao Sun, Jing-Gung Zhou, Qing Ding, and Pi-Jin Wei. 2014. “Synthetic Polypeptide Derived from Viral Macrophage Inflammatory Protein II Inhibit VEGF Production of Human Glioma U87 Cells through SDF-1a/CXCR4-Mediated AKT Signaling Pathway.” Tropical Journal of Pharmaceutical Research 13 (8): 1327–32. doi:10.4314/tjpr.v13i8.18.